跳至主要内容
临床试验/NCT07630402
NCT07630402招募中不适用

Pilot Study for Optimization of Cardiac Imaging in Women With Early-Stage Breast Cancer

University of Rochester1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2025年11月17日最近更新:

试验速览

阶段
不适用
状态
招募中
入组人数
20
试验地点
1

研究概览

简要总结

The purpose of this study is to determine whether a personalized, risk-stratified surveillance strategy can safely reduce unnecessary cardiac imaging while preserving early detection of treatment-related cardiotoxicity in women with breast cancer (BC) receiving HER2-targeted therapy (HER2-TT).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 79 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Female sex, age 18-79 years.
  • Histologically confirmed HER2-positive BC scheduled for ≈12 months of adjuvant HER2-TT
  • Baseline LVEF ≥ 55 % by 2-D echocardiography.
  • Ability to provide informed consent.

排除标准

  • Prior HF, myocardial infarction, or cardiomyopathy.
  • Atrial fibrillation or significant valvular heart disease.
  • Cumulative anthracycline dose ≥ 250 mg/m².
  • Pregnancy or lactation.
  • Inability to comply with study procedures.

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Farhan Bajwa

Assistant Professor

University of Rochester

研究点 (1)

Loading locations...

相似试验